课题基金 / 基金详情

Understanding and Manipulating the Protein-Protein Interactions of Aurora A Kinase using Chemical Biology approaches

Understanding and Manipulating the Protein-Protein Interactions of Aurora A Kinase using Chemical Biology approaches
使用化学生物学方法理解和操纵 Aurora A 激酶的蛋白质-蛋白质相互作用
批准号:
2600962
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
化学探针的独特之处在于,它们可以以剂量和时间依赖的方式调节蛋白质功能。它们可以用来理解蛋白质与疾病过程的相关性,并作为药物发现的起点。虽然识别蛋白质相互作用抑制物(PPI)的方法已经建立起来,但针对涉及固有无序区域(IDR)的PPI的方法还没有很好地开发出来。该项目将开发能够实现物理科学的方法--特别是利用共价蛋白质标记--来表征、抑制和跟踪固有无序蛋白质的细胞内相互作用,重点是Aurora A Kinase与N-MYC、TPX-2和TACC3的相互作用。Aurora A在细胞生命周期中扮演着重要的角色,例如在细胞分裂中,这一过程在癌症中变得有缺陷,使其成为抗癌药物发现努力的焦点。其目的和目标LifeArc的案例学习将建立在广泛的初步结构数据的基础上,以(I)了解Aurora A PPI的预先组织的模拟肽调节剂的影响,(Ii)利用动态连接筛选来确定Aurora A PPI的肽-小分子杂交调节器,以及(Iii)设计具有新反应弹头的共价化学探针,用于细胞Aurora A标记。学生将获得合成、肽/蛋白质化学和生物物理学方面的技能,并通过与项目合作伙伴的合作(I)获得配体发现方法的技术能力(Ii)培养翻译思维。潜在的应用和益处这些工具的开发将解决缺乏物理科学方法来识别IDR的化学探针的问题,并揭示Aurora A激酶关键调节因子的功能作用以揭示替代治疗策略。调整PPI对于未来的医疗创新和治疗具有巨大社会负担的多种疾病至关重要,例如癌症、炎症性疾病等。因此,开展这项研究将有助于EPSRC繁荣成果:健康国家和21世纪产品。
英文摘要
Chemical probes are unique in that they can in a dose and time dependent manner modulate protein function. They can be used to understand the relevance of a protein to a disease process and as starting points for drug discovery. Whilst methods to identify inhibitors of protein-protein interactions (PPI) are becoming established, methods to target PPIs involving intrinsically disordered regions (IDRs) are not well developed. This project will develop enabling physical sciences methods - specifically exploiting covalent protein labelling - to characterize, inhibit and track the intracellular interactions of intrinsically disordered proteins focusing on interactions of the Aurora A Kinase with N-MYC, TPX-2 and TACC3. Aurora A plays an essential role in the cells life-cycle e.g. in cell-division, a process that becomes defective in cancer making it a focus of anticancer drug discovery efforts.Its aims and objectives The CASE studentship with LifeArc will build on extensive preliminary structural data to (i) understand the affects of pre-organise peptidomimetic modulators of Aurora A PPIs, (ii) exploit dynamic ligation screening to identify peptide-small molecule hybrid modulators of Aurora A PPIs and (iii) design covalent chemical probes with new reactive warheads for in cell Aurora A Labelling. The student will gain skills in synthesis, peptide/protein chemistry and biophysics and through collaboration with the project partner (i) gain technical competences in ligand discovery methods (ii) develop a translation mindset.Potential applications and benefitsDevelopment of these tools will address a lack of physical sciences approaches to identify chemical probes for IDRs and reveal insight on the functional role of key regulators of the Aurora A kinase to reveal alternative therapeutic strategies. Modulating PPIs is critical to future healthcare innovation and treatment of multiple diseases with huge societal burdens, e.g. cancer, inflammatory diseases etc. Pursuing this research will thus contribute to the EPSRC prosperity outcomes: Healthy Nation and 21st Century products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金